Advancing the science of multiple sclerosis

Aventaris develops targeted therapies for immune-mediated neurological disease, grounded in rigorous clinical research.

Explore our medicines Ask Medical Information →

Our medicines

Neuravia® (velozumab)

injection for subcutaneous use

A targeted B-cell therapy for adults with relapsing forms of multiple sclerosis.

Prescribing Information → Patient resources → Ask Medical Information →

Important Safety Information

This section would carry Neuravia®'s full Important Safety Information — including contraindications, warnings and precautions, and the most common adverse reactions — alongside a link to the complete Prescribing Information.

Reporting a side effect? Report suspected adverse events to Aventaris Drug Safety or your national reporting authority.